Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug delivery

Title
Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug delivery
Authors
Keywords
Prodrug nanoparticle, Self-assembly, Tumor microenvironment, Cancer immunotherapy, Combination therapy
Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume 183, Issue -, Pages 114177
Publisher
Elsevier BV
Online
2022-03-01
DOI
10.1016/j.addr.2022.114177

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started